We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DEST
2651
DELISTED
Destination Maternity Corporation
DEST
| $280K | ﹤0.01% |
18,614
+1,100
| +6% | +$17.3K |
|
|
KEM
2652
DELISTED
KEMET Corporation
KEM
| $279K | ﹤0.01% |
67,342
+3,000
| +5% | +$12.4K |
|
|
MOFG
2653
DELISTED
MidWestOne Financial Group
MOFG
| $278K | ﹤0.01% |
9,644
+600
| +7% | +$17.1K |
|
|
NWBO
2654
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $278K | ﹤0.01% |
37,695
+7,950
| +27% | +$53.5K |
|
2655
Sierra Bancorp
BSRR
$530M
| $277K | ﹤0.01% |
16,560
+800
| +5% | +$13.1K |
|
|
ACGN
2656
DELISTED
Aceragen Inc
ACGN
| $277K | ﹤0.01% |
550
+157
| +40% | +$95.7K |
|
|
FBRC
2657
DELISTED
FBR & Co. Common Stock
FBRC
| $277K | ﹤0.01% |
11,999
+500
| +4% | +$11.9K |
|
|
TNAV
2658
DELISTED
Telenav Inc.
TNAV
| $276K | ﹤0.01% |
34,873
+1,800
| +5% | +$13.9K |
|
|
PGEM
2659
DELISTED
Ply Gem Holdings, Inc.
PGEM
| $276K | ﹤0.01% |
21,237
+2,450
| +13% | +$32.2K |
|
|
ADVM
2660
DELISTED
Adverum Biotechnologies
ADVM
| $275K | ﹤0.01% |
680
+268
| +65% | +$113K |
|
|
UCTT
2661
Ultra Clean Holdings
UCTT
$3.78B
| $275K | ﹤0.01% |
38,453
+1,400
| +4% | +$12.3K |
|
|
EMCI
2662
DELISTED
EMC INS Group Inc
EMCI
| $275K | ﹤0.01% |
12,194
+450
| +4% | +$9.77K |
|
|
NVRO
2663
DELISTED
NEVRO CORP.
NVRO
| $274K | ﹤0.01% |
+5,720
| New | +$248K |
|
|
KYO
2664
DELISTED
Kyocera Adr
KYO
| $274K | ﹤0.01% |
4,987
+537
| +12% | +$26K |
|
|
SCMP
2665
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $273K | ﹤0.01% |
17,513
+2,780
| +19% | +$43.1K |
|
2666
Daily Journal
DJCO
$794M
| $271K | ﹤0.01% |
1,477
+72
| +5% | +$14.3K |
|
|
GTT
2667
DELISTED
GTT Communications, Inc.
GTT
| $271K | ﹤0.01% |
14,355
+4,275
| +42% | +$62.2K |
|
2668
Capital City Bank Group
CCBG
$893M
| $270K | ﹤0.01% |
16,604
+700
| +4% | +$10.8K |
|
2669
TechTarget
TTGT
$310M
| $269K | ﹤0.01% |
23,302
+1,100
| +5% | +$12.6K |
|
|
HTBK
2670
DELISTED
Heritage Commerce
HTBK
| $268K | ﹤0.01% |
29,382
+1,400
| +5% | +$12.2K |
|
2671
RadNet
RDNT
$5.37B
| $268K | ﹤0.01% |
31,935
+6,075
| +23% | +$50.8K |
|
2672
Immersion
IMMR
$246M
| $267K | ﹤0.01% |
29,118
+4,400
| +18% | +$38.9K |
|
2673
LGI Homes
LGIH
$1.37B
| $267K | ﹤0.01% |
16,030
+1,400
| +10% | +$19.7K |
|
|
PSIX
2674
Power Solutions International
PSIX
$762M
| $267K | ﹤0.01% |
+4,152
| New | +$217K |
|
|
MFLX
2675
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
| $267K | ﹤0.01% |
14,621
+600
| +4% | +$9.41K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.